We have at our disposal a highly qualified and experienced Supervisory Board which is composed of the following members:
Prof. Dr. Eric-Paul Pâques
Chairman of the Board
Prof. Pâques is presently Member of the Corporate Executive Board of Grünenthal, an international research-based pharmaceutical company headquartered in Aachen, Germany.
Dr. Berthold Hinzen
Member of the Board
After studying Chemistry Dr. Hinzen joined Bayer AG, where he worked in a variety of capacities in chemical drug development and marketing. Today he is the Head of a Business Development and Licensing Group, one of four business units of Bayer-Schering Pharma, Berlin, Germany; he is responsible for the cardiovascular system segment (incl. Cardiology) as well as Anti-Infections, Diabetes, Urology and Pulmonology.